“The development of suitable blood-based biomarkers to predict outcomes is important for neurodegenerative diseases such as PD, which progress over many years. The markers that we have identified need to be validated in further studies but could ultimately help with planning more targeted management for patients earlier in their disease course. Furthermore, a better understanding of the biological changes that predict disease course has implications for possible future therapies for the disease,” said Dr. Gabriele Saretzki of Newcastle University, corresponding author of a new study investigating blood-based biomarkers for Parkinson’s progression

 

https://www.journalofparkinsonsdisease.com/simple-blood-test-could-help-predict-progression-parkinsons-disease